The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau

Providing an early, additional measles vaccine (MV) at 4.5 months of age has been shown to reduce child mortality in low-income countries. We studied the effects on growth at 9 and 24 months of age. A randomized controlled trial was conducted in Guinea-Bissau from 2003-2007 including 6,648 children....

Ausführliche Beschreibung